☆ 3.8 Letter

The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention?

GYNECOLOGIC ONCOLOGY REPORTS (2015)

Get Full Text
Add to Collection

Journal

GYNECOLOGIC ONCOLOGY REPORTS
Volume 13, Issue -, Pages 47-48

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.gore.2015.06.009

Keywords

-

Categories

Obstetrics & Gynecology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.